Anti-Ferritin Heavy Chain antibody [EPR3005Y] (Ab75972)

FTH, FTHL6, OK/SW-cl.84, PIG15, FTH1, Ferritin heavy chain, Ferritin H subunit, Cell proliferation-inducing gene 15 protein

反应种属:Human
抗原名称:FTH1
应用:WB, IHC

详细信息

免疫原The exact immunogen used to generate this antibody is proprietary information.
宿主/亚型Rabbit / IgG
抗体类型Monoclonal
产品形式Liquid
纯化方式Affinity purification Protein A
储存缓冲液pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
储存条件运输条件: Conditional Ambient 推荐的短期储存时间: 1-2 weeks 推荐的短期储存条件: +4°C 推荐的长期储存条件: -20°C 储存信息: Avoid freeze / thaw cycle
无载体蛋白No

特异性

This antibody recognizes only the Ferritin heavy chain. Clone EPR3005Y has low sensitivity in WB, for low expression samples please use clone EPR3004Y (product ab75973).

背景信息

What is this antibody validated in? Anti-Ferritin Heavy Chain antibody [EPR3005Y] (ab75972) is a rabbit recombinant monoclonal antibody and is validated for use in Western Blot (WB), Immunohistochemistry (IHC-P) in Human samples. What is the molecular weight of Ferritin Heavy Chain? Anti-Ferritin Heavy Chain [EPR3005Y] (ab75972) specifically detects a band for Ferritin Heavy Chain (UniProt: P02794) at a molecular weight of 21kDa. Trusted by the scientific community Anti-Ferritin Heavy Chain [EPR3005Y] (ab75972) was first used in a scientific publication in 2009 and has been cited over 30 times in peer-reviewed journals. Other related products We have a range of other formats of antibody clone [EPR3005Y] also available for your convenience: ab75972, Carrier free - ab247418, APC - ab319237, PE - ab319385, Alexa Fluor ® 488 - ab319519, Alexa Fluor ® 647 - ab319632, Alexa Fluor ® 594 - ab319736, Alexa Fluor ® 555 - ab319878, Alexa Fluor ® 750 - ab321705 Trial sizes available! Test your antibody or perform pre-screening before committing to a larger quantity. Sold in 20µl. Discover our selection of trial-size antibodies. Species reactivity Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species. Please contact us for more information. Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents. What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies.

文献引用 (62)

Heme as a Pro-Inflammatory Stimulus in Abdominal Aortic Aneurysm.

血红素作为腹主动脉瘤的促炎刺激物。

Ding Yuchao, Potor László, Sótonyi Péter, Szappanos Ágnes, Gyurok Gergő Péter, Póliska Szilárd, Patsalos Andreas, Méhes Gábor, Beke Lívia, Sikura Katalin Éva, Zavaczki Erzsébet, Gáll Tamás, Pethő Dávid, Fintha Attila, Nagy Beáta, Juhász Béla, Nagy László, Balla György, Balla József

YTHDC2 Deficiency Exacerbates Ulcerative Colitis by Stabilizing RBMS1 mRNA to Drive Epithelial Ferroptosis.

YTHDC2 缺乏通过稳定 RBMS1 mRNA 来驱动上皮细胞铁死亡,从而加剧溃疡性结肠炎。

Qiu Bo, Fu Zhongbiao, Wang Haihua, Bai Feihu

S100P is a ferroptosis suppressor to facilitate hepatocellular carcinoma development by rewiring lipid metabolism

S100P 是一种铁死亡抑制剂,通过重新连接脂质代谢来促进肝细胞癌的发展

Min Yang #, Weiwei Cui #, Xiaoting Lv, Gaozhong Xiong, Caiyu Sun, Haocheng Xuan, Wei Ma, Xiuling Cui, Yeping Cheng, Lihui Han, Bo Chu

Dual-Targeting Strategy to Repurpose Cetuximab with HFn Nanoconjugates for Immunotherapy of Triple-Negative Breast Cancer.

利用 HFn 纳米偶联物对西妥昔单抗进行双靶点策略,用于三阴性乳腺癌的免疫治疗

Barbieri Linda, Salvioni Lucia, Banfi Andrea, Garbujo Stefania, Fiandra Luisa, Baioni Chiara, Giustra Marco, Morelli Lucia, Frascotti Gianni, Colombo Miriam, Innocenti Metello, Prosperi Davide

Oxidative stress activates YAP/TEAD1/NCOA4 axis to promote ferroptosis of endplate chondrocytes and aggravate intervertebral disc degeneration.

氧化应激激活 YAP/TEAD1/NCOA4 轴,促进终板软骨细胞铁死亡,加剧椎间盘退变

Wang Heran, Liu Xiaodong, Jing Xingzhi, Zhang Bofei, Liu Xin, Liu Xiaoyang, Jia Fei, Su Cheng, Wang Wenchao, Cui Xingang

Targeting PTGDS Promotes ferroptosis in peripheral T cell lymphoma through regulating HMOX1-mediated iron metabolism

靶向 PTGDS 通过调节 HMOX1 介导的铁代谢促进外周 T 细胞淋巴瘤中的铁死亡

Shunfeng Hu, Bingyu Liu, Juanjuan Shang, Qianqian Guo, Tiange Lu, Xiaoli Zhou, Xiangxiang Zhou, Xin Wang1

CUL2 confers ferroptosis resistance in pancreatic cancer by disrupting KEAP1-mediated NRF2 degradation.

CUL2 通过破坏 KEAP1 介导的 NRF2 降解,赋予胰腺癌细胞铁死亡抵抗力。

Yu Kui, Chen LiLi, Zhong Yong, Wang Yang, Zhu Na, Wang Daoheng, Yao Wenyan, Bai Haoran, Yang Lijuan, Qi Dachuan

Molecular mechanism of ZC3H13 -mediated ferroptosis in doxorubicin resistance of triple negative breast cancer

ZC3H13介导的铁死亡在三阴性乳腺癌阿霉素耐药中的分子机制

Li Huang, Lei Han, Shuai Liang, Guohui Han

Obacunone inhibits ferroptosis through regulation of Nrf2 homeostasis to treat diabetic nephropathy.

Obacunone 通过调节 Nrf2 稳态抑制铁死亡,从而治疗糖尿病肾病

Ou Yi, Zhang Wenjuan

METTL3/YTHDF3 m(6)A axis promotes ferroptosis in diabetic kidney disease by stabilizing TfR1.

METTL3/YTHDF3 m(6)A 轴通过稳定 TfR1 促进糖尿病肾病中的铁死亡

Zhang Jinmei, Zhou Xiaoping, Wang Bin, Yin Yan, Wei Daihao, Li Kun
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7